Get the Stockscreener App
8.474
2.49%
-0.216
Capsovision Inc stock is traded at $8.474, with a volume of 194.10K.
It is down -2.49% in the last 24 hours and up +62.03% over the past month.
CapsoVision Inc is a commercial-stage medical technology enterprise, innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. Internal GI imaging facilitates earlier detection of colorectal cancer and other diseases, enabling more timely and effective treatment regimens for patients. The Company's core technology platform is an orally ingestable capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. The Company's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D directed at the large intestines.
See More
Previous Close:
$8.69
Open:
$8.63
24h Volume:
194.10K
Relative Volume:
0.48
Market Cap:
$421.29M
Revenue:
$12.60M
Net Income/Loss:
$-23.72M
P/E Ratio:
-16.64
EPS:
-0.5092
Net Cash Flow:
-
1W Performance:
+55.20%
1M Performance:
+62.03%
6M Performance:
+86.24%
1Y Performance:
+0.00%
1-Day Range:
$8.39
$9.17
1-Week Range:
$5.36
$9.17
52-Week Range:
$3.4341
$15.37
Capsovision Inc Stock (CV) Company Profile
Name
Capsovision Inc
Sector
Industry
Phone
(408) 370-4790
Address
18805 COX AVENUE SUITE 250, SARATOGA
Compare CV vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
8.475 | 431.98M | 12.60M | -23.72M | 0 | -0.5092 |
ABT
Abbott Laboratories
|
104.77 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
326.58 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.44 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.31 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.68 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-25 | Initiated | Roth Capital | Buy |
| Jul-28-25 | Initiated | The Benchmark Company | Speculative Buy |
Capsovision Inc Stock (CV) Latest News
CapsoVision Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView
CapsoVision Conference: CEO Maps AI-Driven Capsule Endoscopy Roadmap for Colon and Pancreas Screening - MarketBeat
CapsoVision (CV) director receives 4,045 RSU equity award - Stock Titan
CapsoVision (CV) awards 4,045 RSUs to board director - Stock Titan
CapsoVision (CV) director receives 4,045 RSU grant as board compensation - Stock Titan
CapsoVision (CV) director receives 4,045 RSUs vesting through 2026 - Stock Titan
CapsoVision (CV) awards 4,045 restricted stock units to director - Stock Titan
[Form 4] CapsoVision, Inc Insider Trading Activity - Stock Titan
CV: CapsoVision advances AI-powered capsule endoscopy with strong pipeline and global expansion - TradingView
CapsoVision’s Strategic Moves Spike Stock as Market Anticipates Growth - timothysykes.com
CapsoVision Surges 13% on Closing $14M Private Placement - StocksToTrade
CapsoVision, Inc.: Fundamental Analysis and Financial Ratings | H6U | US1409351079 - marketscreener.com
CapsoVision Closes $14 Million Private Placement and Reports Preliminary 2025 Financial Results - Minichart
CapsoVision Raises Capital and Refocuses Colon Capsule Strategy - TipRanks
CapsoVision closes $14 million private placement financing - Investing.com
CapsoVision Raises ~$14 Million in Private Placement, Selling 2.87M Shares at $4.883 - TradingView
CapsoVision (NASDAQ: CV) secures $14M and pivots colon capsule strategy - Stock Titan
Fresh $14M gives CapsoVision cash to fund AI and capsule scope push - Stock Titan
What Is CapsoVision's Roadmap For Growth And Innovation In 2026? - RTTNews
CapsoVision Inc Trading Resumes - MSN
CapsoVision, Inc. Announces Amendment to Sample Purchase Agreement with Canon Inc. for CMOS Image Sensor Development 5 - Minichart
CapsoVision increases development fee in amended agreement with Canon - Investing.com
CapsoVision Amends Canon Agreement for Upgraded Image Sensors - TipRanks
CapsoVision (NASDAQ: CV) adds $1M to Canon CMOS sensor deal - Stock Titan
Analyzing CapsoVision (CV) and Its Peers - Defense World
CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026 - Bitget
AI-enabled capsule endoscopy firm CapsoVision sets March 26 earnings call - Stock Titan
Electronic Pill Market Is Going to Boom Rapidly | Medtronic plc, CapsoVision Inc., IntroMedic Co. Ltd. - openPR.com
CapsoVision to Participate in the 38th Annual ROTH Conference - Bitget
Critical Analysis: CapsoVision (CV) and Its Competitors - Defense World
CapsoVision price target raised to $14 from $5 at Benchmark - MSN
CapsoVision submits FDA 510(k) for AI-assisted module in CapsoCam Plus - MSN
Reviewing CapsoVision (CV) and Its Rivals - Defense World
CapsoVision, Inc. (NASDAQ:CV) Short Interest Update - Defense World
CapsoVision (CV) & Its Competitors Critical Contrast - Defense World
Critical Survey: CapsoVision (CV) versus Its Rivals - Defense World
CapsoVision (CV) and Its Competitors Head-To-Head Review - Defense World
CapsoVision (CV) & Its Competitors Head to Head Survey - Defense World
Financial Review: CapsoVision (CV) & Its Peers - Defense World
Head-To-Head Contrast: CapsoVision (CV) versus Its Competitors - Defense World
Critical Contrast: CapsoVision (CV) versus Its Rivals - Defense World
Head-To-Head Comparison: CapsoVision (CV) versus The Competition - Defense World
CapsoVision (NASDAQ:CV) and Profusa (NASDAQ:PFSA) Head-To-Head Review - Defense World
CapsoVision (CV) vs. Its Competitors Financial Analysis - Defense World
Reviewing CapsoVision (CV) & Its Competitors - Defense World
Is CapsoVision (NASDAQ:CV) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Head to Head Contrast: CapsoVision (CV) & Its Competitors - Defense World
Contrasting CapsoVision (CV) and The Competition - Defense World
Short Interest in CapsoVision, Inc. (NASDAQ:CV) Increases By 281.0% - MarketBeat
CapsoVision prices $27.5M IPO - MSN
Short Interest in CapsoVision, Inc. (NASDAQ:CV) Declines By 57.4% - MarketBeat
Capsovision Inc Stock (CV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Capsovision Inc Stock (CV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| GOUW JULIA S | Director |
Dec 31 '25 |
Option Exercise |
10.69 |
2,887 |
30,862 |
2,887 |
| Imperial Joanne Carol | Director |
Dec 31 '25 |
Option Exercise |
10.69 |
2,887 |
30,862 |
2,887 |
| King Wen-Herng Henry | Director |
Dec 31 '25 |
Option Exercise |
10.69 |
2,887 |
30,862 |
23,597 |
| Kuo Hui Ying | Director |
Dec 31 '25 |
Option Exercise |
10.69 |
2,887 |
30,862 |
13,241 |
| Tsai Chen Lung | Director |
Dec 31 '25 |
Option Exercise |
10.69 |
2,887 |
30,862 |
2,887 |
| Petersen Rebecca Ann | Director of Clinical Affairs |
Aug 18 '25 |
Option Exercise |
0.37 |
24,834 |
9,097 |
24,834 |
1.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):